A Phase I Clinical Trial Of Hepatic Arterial Infusion Of Oxaliplatin And Oral Capecitabine, With Or Without Systemic Bevacizumab, For Patients With Advanced Cancer And Liver Involvement.

Elena Fountzilas,Elangovan Krishnan,Filip Janku,Siqing Fu,Daniel D. Karp,Aung Naing,Vivek Subbiah,David S. Hong,Sarina Anne Piha-Paul,David J. Vining,Apostolia M. Tsimberidou

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 0|浏览16

暂无评分

摘要

2527Background: Hepatic arterial infusion (HAI) of chemotherapy is a treatment option for patients (pts) with cancer metastatic to the liver. We investigated HAI oxaliplatin combined with capecitab...

查看译文

关键词

hepatic arterial infusion,systemic bevacizumab,oxaliplatin,oral capecitabine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要